Stay updated on Ixazomib Citrate for Relapsed Myeloma Clinical Trial

Sign up to get notified when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T23:29:15.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the removal of detailed information about a phase II trial for ixazomib citrate in treating relapsed multiple myeloma, while adding new identifiers and a revision number.
    Difference
    44%
    Check dated 2025-04-17T07:08:38.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 13, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.2%
    Check dated 2025-04-09T23:48:33.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.3) and a more recent last update date (2025-03-25), replacing the previous version (v2.14.2) and date (2025-02-13).
    Difference
    0.2%
    Check dated 2025-04-02T20:20:45.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-02-24T22:54:41.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The webpage has updated its date references, removing older dates and adding new ones for February 2025. This indicates a shift in the timeline of the content presented.
    Difference
    0.5%
    Check dated 2025-02-17T19:06:42.000Z thumbnail image

Stay in the know with updates to Ixazomib Citrate for Relapsed Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.